ArisGlobal Launches Enterprise-Level Document Management Platform

LifeSphere® EasyDocs enables the life sciences industry to
eliminate multiple siloed applications and reduce integration
complexities while unifying document management

Miami (ots/PRNewswire) - ArisGlobal, a leading provider of life
sciences software that automates core drug development functions for
over 200 global life sciences companies, today announced the release
of LifeSphere® EasyDocs (https://goo.gl/KpDeJX), an advanced cloud
platform that streamlines enterprise document management across the
product development lifecycle. Seamlessly woven into ArisGlobal's
LifeSphere® ecosystem, which includes the LifeSphere® Clinical,
Regulatory, Safety and Medical Affairs platforms, life sciences
organizations will now have a highly configurable, scalable solution
that gives users a unified view of content and data across all
domains. LifeSphere® EasyDocs significantly improves user
productivity and operational efficiency, and delivers the critical
'single source of truth' for assured compliance across the end-to-end
development lifecycle.

"Today's life sciences company wants to achieve faster document
approvals that meet both changing compliance requirements and global
business needs for collaboration. An enterprise content management
solution, unified across the end-to-end product development
lifecycle, can make the difference by enabling improved
communication, collaboration, visibility and process efficiency over
data and content, and ultimately help achieve faster document
approval," said Sankesh Abbhi (https://goo.gl/piYcfB), President and
CEO of ArisGlobal. "LifeSphere EasyDocs, using ArisGlobal's
platform-based approach, is highly configurable and designed to
support various business processes and document types, while ensuring
the flow of information across drug development functions. It offers
the potential to replace disparate point solutions, lowering
technology costs and increasing return on investment."

LifeSphere EasyDocs offers the following capabilities as part of
its unified platform for document and content management:

- Advanced document management platform with highly configurable
lifecycle and workflow management modules
- Cross-domain 'Single source of truth' for all types of documents in
drug development functions
- An intuitive, easy-to-use and mobile-enabled user interface
- Seamless integration with the entire LifeSphere® ecosystem that
includes clinical, regulatory, safety and medical information
- Open SOA architecture and highly interoperable API library,
offering easy integration with third-party systems
- Pre-validated deployment on the state-of-the-art Amazon Web
Services (AWS) cloud

ArisGlobal is also announcing LifeSphere® Publishing
(https://goo.gl/wQ4hBC), part of the LifeSphere® Regulatory platform
(https://goo.gl/XBfiMU), giving companies a cloud-based solution for
compiling, publishing and validating regulatory submissions, with
full support for all major global eCTD requirements.

Learn more: LifeSphere EasyDocs (https://goo.gl/YLk6Ao)

About ArisGlobal

ArisGlobal is a visionary technology company that's transforming
the way today's most successful Life Sciences companies develop
breakthroughs and bring new products to market. Our end-to-end drug
development technology platform, LifeSphere®, integrates our
proprietary Nava® cognitive computing engine to automate all core
functions of the drug development lifecycle. Designed with deep
expertise and a long-term perspective that spans more than 30 years,
LifeSphere® boosts efficiency, ensures compliance, delivers
actionable insights, and lowers total cost of ownership through
multi-tenant Software-as-a-Service (SaaS) architecture. Headquartered
in the United States, ArisGlobal has regional offices in Europe,
India, Japan and China. Visit arisglobal.com (https://goo.gl/fpFnXY),
or follow ArisGlobal on LinkedIn
(https://www.linkedin.com/company/aris-global/) and Twitter
(https://twitter.com/Aris_Global).

ots Originaltext: ArisGlobal
Im Internet recherchierbar: http://www.presseportal.de

Contact:
+1.978.697.5897
gbelkin@arisglobal.com

Original-Content von: ArisGlobal, übermittelt durch news aktuell